4//SEC Filing
Schultz Kare 4
Accession 0001209191-22-014473
CIK 0000818686other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:51 AM ET
Size
7.6 KB
Accession
0001209191-22-014473
Insider Transaction Report
Form 4
Schultz Kare
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Ordinary Shares
2022-02-28+65,047→ 1,132,496 total - Exercise/Conversion
Restricted Share Units
2022-02-28−65,047→ 130,096 total→ Ordinary Shares (65,047 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on February 28, 2020, with 65,047 having vested on each of February 28, 2021 and February 28, 2022, 65,047 vesting on February 28, 2023 and 65,049 vesting on February 28, 2024.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001724567
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:51 AM ET
- Size
- 7.6 KB